follow us in feedly
MicroSmallCap

Join Our Community

Facebook

Twitter

RSS

      • Featured
      • Penny Stocks
        • Penny Stocks to Buy
        • Penny Stocks to Sell
        • Robinhood Penny Stocks
      • Robinhood Stocks
        • Top 100
        • Penny Stocks
      • Market Movers
        • Analyst Coverage
        • Earnings Reports
        • Low Float Stocks
        • PDUFA Stage
        • Short Squeeze Stocks
        • Stock Price Target Changes
        • Stocks to Buy
        • Stocks to Sell
      • Sectors
        • Cannabis
        • Consumer
        • Energy
        • Financial
        • Health
        • Mining
        • Tech
      • NewsHub
      Home2022

      Year: 2022

      Health

      Silk Road Medical (SILK) Reports Q1 Loss, Tops Revenue Estimates

      May 4
      Silk Road Medical (SILK) came out with a quarterly loss of $0.48 per share versus the Zacks Consensus Estimate of a loss of $0.41. This compares to loss of $0.31 per share a year ago. ... [Read]
      Penny Stocks to Buy

      3 Red-Hot Psychedelic Stocks to Buy in May 2022

      May 3 jetlee
      According to Forbes, investors are getting more bullish on the psychedelic industry. And part of the reason is because research noted that this sector could bring in a whopping $6.85 billion by 2027. When compared ... [Read]
      Biotechnology

      Codexis to Present Data Highlighting Three Gene Therapy Programs at the ASGCT 25th Annual Meeting

      May 2
      REDWOOD CITY, Calif., May 02, 2022 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company enabling the promise of synthetic biology, today announced two poster presentations highlighting three of the Company’s gene ... [Read]
      Health

      Exagen Announces Five-Week Campaign for Lupus Awareness Month

      May 1
      SAN DIEGO, May 01, 2022 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced, in recognition of Lupus Awareness Month, the launch of a five-week awareness campaign to highlight important ... [Read]
      Alternative Energy

      Tech Giants Commit Nearly $1 Billion Toward Carbon Capture

      Apr 28 Stéphanie Bédard-Châteauneuf
      Some of the world’s largest companies are teaming up to commit nearly $1 billion in spurring the carbon-capture market. On April 12, Stripe, Facebook, Alphabet, Shopify and McKinsey & Co. Inc. announced the creation of ... [Read]
      EV Technology Group
      Editorspicks

      EV Technology Group prepares for global growth with the appointment of former Lotus executive Dan Burge as Chief Product Officer and the opening of new United States office

      Apr 25 EV Technology Group
      TORONTO, April 25, 2022 – EV Technology Group Ltd., (NEO:EVTG) (the “Company”) announces today that it has strengthened its leadership team with the appointment of Dan Burge as Chief Product Officer, effective immediately. Dan Burge is ... [Read]
      Editorspicks

      Global Antibiotic Resistance Market to Hit US$16.5 Billion By 2030

      Apr 21 Stéphanie Bédard-Châteauneuf
      Resistance to antibiotics is a growing concern. About 750,000 people die each year worldwide from drug–resistance infections. If solutions aren’t found and put in place, 10 million people could die from antibiotic resistance-related diseases by ... [Read]
      Tech

      Shenandoah Telecommunications Company Reports Q4 2021 and FY 2021 Results With Growth for Shentel

      Apr 20 Matthew Evanoff
      Shenandoah Telecommunications Company (NASDAQ:SHEN) announced its fourth quarter and full year financial and operating results on February 28, 2022. The telecom company, known as Shentel, provides broadband services. The company has high-speed, cable, fiber-optic, and ... [Read]
      Health

      Why Psychedelics Could Soon Replace Antidepressants

      Apr 13 Stéphanie Bédard-Châteauneuf
      Anxiety disorders are the most common mental illness in the US, affecting approximately 40 million adults each year, and despite the abundance of antianxiety medications available, treatment resistance occurs in roughly 30% of patients. Anxiety ... [Read]
      Biotechnology

      BridgeBio Pharma Announces Phase 2 Results From Acoramidis Study

      Apr 11 Matthew Evanoff
      BridgeBio Pharma (NASDQ:BBIO), a commercial-stage biopharmaceutical company developing medicines for patients suffering from genetic diseases and cancers with clear genetic drivers, recently reported updated results from its ongoing Phase 2 study for acoramidis. The study ... [Read]

      Posts pagination

      « 1 … 7 8 9 … 11 »

      YOU MAY ALSO LIKE

      • Optimi Health
        Optimi Health Has Completed the Largest Legal Harvest of Natural Psilocybin in Canadian History.
        Sep 15 Chinedu Okoro
      • Cardinal Health Reveals Governance Enhancements And Shareholder Value Creation Programs
        Cardinal Health Reveals Governance Enhancements And Shareholder Value Creation Programs
        Sep 9 Adewumi Victor
      • HBO Max Eliminates Approximately 200 'Sesame Street' Episodes
        HBO Max Eliminates Approximately 200 ‘Sesame Street’ Episodes
        Aug 19 Peter Olaoluwapo
      • Blue Water Assumes Administration of Rising River RV Resort and River House
        Blue Water Assumes Administration of Rising River RV Resort and River House
        Aug 19 Peter Olaoluwapo
      • FDA Approves Bayer’s Nubeqa for Wider Use in Prostate Cancer Subtype.
        FDA Approves Bayer’s Nubeqa for Wider Use in Prostate Cancer Subtype.
        Aug 9 Peter Olaoluwapo
      Subscribe & Get The LATEST Stock Pick Alerts
      I want e-mail alerts, updates, and offers and agree to the MicroSmallCap privacy policy.
      Advertise With Us
      • Write for Us
      • Submit Press Release
      • Submit Sponsored Post
      Company
      • Authors
      • Contact Us
      Legal
      • Terms of Use
      • Privacy Policy
      • DMCA Policy
      • Disclaimer
      Follow Us

      Copyright © 2026 | #170 - 422 Richards Street Vancouver, BC, Canada V6B 2Z4 | 1.800.340.9767

      Copyright © 2026 | Terms of Use | Privacy Policy | DMCA | Disclaimer | Authors

      #170 - 422 Richards Street Vancouver, BC, Canada V6B 2Z4 | 1.800.340.9767

      Subscribe & Get FREE ReWalk Robotics Ltd. Email Alerts
      Get FREE ReWalk Robotics Ltd. Email Alerts
      I want e-mail alerts, updates, and offers and agree to the MicroSmallCap privacy policy.
      x